DE3348370C2
(de)
*
|
1982-10-08 |
2001-10-11 |
Glaxo Group Ltd |
Medikamenten-Packung und Verfahren zur Erzeugung eines zur Inhalation bestimmten Medikamenten-Pulver-Luftstroms
|
SE448277B
(sv)
*
|
1985-04-12 |
1987-02-09 |
Draco Ab |
Indikeringsanordning vid en doseringsanordning for lekemedel
|
NL8601949A
(nl)
*
|
1985-07-30 |
1987-02-16 |
Glaxo Group Ltd |
Inrichtingen voor het toedienen van medicamenten aan patienten.
|
SE8605130L
(sv)
*
|
1986-07-24 |
1988-01-25 |
Marcus Diamant |
Redskap for utklemning av tabletter fran tablettkartor och liknande
|
US4817800A
(en)
*
|
1987-05-20 |
1989-04-04 |
Surgikos, Inc. |
Fluid injection system cassette and fluid packaging methods
|
FR2626500B1
(fr)
*
|
1988-01-28 |
1990-04-27 |
Valois Sa |
Poussoir de vaporisateur agence pour operer le melange d'un additif dans l'emission du jet
|
CH678151A5
(en)
*
|
1988-07-13 |
1991-08-15 |
Heinz Hermann Weick |
Self-medication nasal dispenser
|
US5239991A
(en)
*
|
1989-06-21 |
1993-08-31 |
Fisons Plc |
Disposable powder medicament inhalation device with peel-off cover
|
GB8914223D0
(en)
*
|
1989-06-21 |
1989-08-09 |
Fisons Plc |
Medicament container
|
IT1230313B
(it)
*
|
1989-07-07 |
1991-10-18 |
Somova Spa |
Inalatore per medicamenti in capsule.
|
DE3927170A1
(de)
*
|
1989-08-17 |
1991-02-21 |
Boehringer Ingelheim Kg |
Inhalator
|
US5009561A
(en)
*
|
1989-08-18 |
1991-04-23 |
Pharmacia Diagnostics Inc. |
Reagent tablet dispenser
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
SK280968B6
(sk)
*
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Balenie medikamentu na použite v inhalačnom prístroji
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
UA26230A
(uk)
*
|
1990-03-02 |
1999-07-19 |
Глексо Груп Лімітед |
Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок
|
GB9012870D0
(en)
*
|
1990-06-08 |
1990-08-01 |
Glaxo Group Ltd |
Device
|
DE4021263C2
(de)
*
|
1990-07-04 |
1996-04-11 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung für Medien
|
IT1243344B
(it)
*
|
1990-07-16 |
1994-06-10 |
Promo Pack Sa |
Inalatore plurimonodose per medicamenti in polvere
|
GB9021433D0
(en)
*
|
1990-10-02 |
1990-11-14 |
Atomic Energy Authority Uk |
Power inhaler
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
US5042472A
(en)
*
|
1990-10-15 |
1991-08-27 |
Merck & Co., Inc. |
Powder inhaler device
|
NL9002706A
(nl)
*
|
1990-12-10 |
1992-07-01 |
Pharmachemie Bv |
Inrichting ten gebruike bij het inhaleren van in staafvormige capsules verpakte poedervormige stoffen.
|
GB2253200A
(en)
*
|
1991-02-01 |
1992-09-02 |
Harris Pharma Ltd |
Inhalation apparatus and fracturable capsule for use therewith
|
US5243970A
(en)
*
|
1991-04-15 |
1993-09-14 |
Schering Corporation |
Dosing device for administering metered amounts of powdered medicaments to patients
|
US5327883A
(en)
*
|
1991-05-20 |
1994-07-12 |
Dura Pharmaceuticals, Inc. |
Apparatus for aerosolizing powdered medicine and process and using
|
US6681767B1
(en)
|
1991-07-02 |
2004-01-27 |
Nektar Therapeutics |
Method and device for delivering aerosolized medicaments
|
US5337740A
(en)
*
|
1991-08-01 |
1994-08-16 |
New England Pharmaceuticals, Inc. |
Inhalation devices
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
DE4142238A1
(de)
*
|
1991-12-20 |
1993-06-24 |
Boehringer Ingelheim Kg |
Pulverinhalator mit pulvertraeger aus regelmaessigen mikrostrukturen
|
GB2264237A
(en)
*
|
1992-02-05 |
1993-08-25 |
Robert Edward Newell |
An inhaler
|
GB9203761D0
(en)
*
|
1992-02-21 |
1992-04-08 |
Innovata Biomed Ltd |
Inhaler
|
US5301664A
(en)
*
|
1992-03-06 |
1994-04-12 |
Sievers Robert E |
Methods and apparatus for drug delivery using supercritical solutions
|
US5394868A
(en)
*
|
1992-06-25 |
1995-03-07 |
Schering Corporation |
Inhalation device for powdered medicaments
|
US5785049A
(en)
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6509006B1
(en)
|
1992-07-08 |
2003-01-21 |
Inhale Therapeutic Systems, Inc. |
Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
|
WO1994008552A2
(en)
*
|
1992-10-19 |
1994-04-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
SE9203743D0
(sv)
*
|
1992-12-11 |
1992-12-11 |
Astra Ab |
Efficient use
|
US6250300B1
(en)
|
1992-12-11 |
2001-06-26 |
Ab Astra |
System for dispensing pharmaceutically active compounds
|
US5368187A
(en)
*
|
1993-01-19 |
1994-11-29 |
Poncetta; Stanley |
Method and apparatus for dispensing materials from blister packages
|
US5743250A
(en)
*
|
1993-01-29 |
1998-04-28 |
Aradigm Corporation |
Insulin delivery enhanced by coached breathing
|
US5970973A
(en)
*
|
1993-01-29 |
1999-10-26 |
Aradigm Corporation |
Method of delivering insulin lispro
|
US5888477A
(en)
*
|
1993-01-29 |
1999-03-30 |
Aradigm Corporation |
Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
|
US5724957A
(en)
*
|
1993-01-29 |
1998-03-10 |
Aradigm Corporation |
Intrapulmonary delivery of narcotics
|
US5934272A
(en)
*
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
US5672581A
(en)
*
|
1993-01-29 |
1997-09-30 |
Aradigm Corporation |
Method of administration of insulin
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US5819726A
(en)
*
|
1993-01-29 |
1998-10-13 |
Aradigm Corporation |
Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease
|
US7448375B2
(en)
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US6131567A
(en)
*
|
1993-01-29 |
2000-10-17 |
Aradigm Corporation |
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
|
US6098620A
(en)
*
|
1993-01-29 |
2000-08-08 |
Aradigm Corporation |
Device for aerosolizing narcotics
|
US5558085A
(en)
*
|
1993-01-29 |
1996-09-24 |
Aradigm Corporation |
Intrapulmonary delivery of peptide drugs
|
US6012450A
(en)
*
|
1993-01-29 |
2000-01-11 |
Aradigm Corporation |
Intrapulmonary delivery of hematopoietic drug
|
US5915378A
(en)
*
|
1993-01-29 |
1999-06-29 |
Aradigm Corporation |
Creating an aerosolized formulation of insulin
|
US5873358A
(en)
*
|
1993-01-29 |
1999-02-23 |
Aradigm Corporation |
Method of maintaining a diabetic patient's blood glucose level in a desired range
|
WO1994020164A1
(en)
*
|
1993-03-03 |
1994-09-15 |
Glaxo Wellcome Inc. |
Dry powder inhalator medicament carrier
|
TW404844B
(en)
|
1993-04-08 |
2000-09-11 |
Oxford Biosciences Ltd |
Needleless syringe
|
US5372128A
(en)
*
|
1993-04-14 |
1994-12-13 |
Habley Medical Technology Corporation |
Fluidizing powder inhaler
|
US5709202A
(en)
*
|
1993-05-21 |
1998-01-20 |
Aradigm Corporation |
Intrapulmonary delivery of aerosolized formulations
|
US5497763A
(en)
*
|
1993-05-21 |
1996-03-12 |
Aradigm Corporation |
Disposable package for intrapulmonary delivery of aerosolized formulations
|
US5533502A
(en)
*
|
1993-05-28 |
1996-07-09 |
Vortran Medical Technology, Inc. |
Powder inhaler with aerosolization occurring within each individual powder receptacle
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
DK0748213T3
(da)
|
1994-03-07 |
2004-08-02 |
Nektar Therapeutics |
Fremgangsmåder og sammensætninger til pulmonal indgivelse af insulin
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
US5664557A
(en)
*
|
1994-03-10 |
1997-09-09 |
Respiratory Delivery Systems, Inc. |
Releasably engageable coupling for an inhaler
|
US6102036A
(en)
*
|
1994-04-12 |
2000-08-15 |
Smoke-Stop |
Breath activated inhaler
|
GB9409851D0
(en)
*
|
1994-05-17 |
1994-07-06 |
Cambridge Consultants |
Improvements in and relating to containers of particulate material
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
ATE387925T1
(de)
|
1994-09-21 |
2008-03-15 |
Nektar Therapeutics |
Vorrichtung und verfahren zum dispergieren von trockenen pulvermedikamenten
|
US5522385A
(en)
*
|
1994-09-27 |
1996-06-04 |
Aradigm Corporation |
Dynamic particle size control for aerosolized drug delivery
|
FR2725626A1
(fr)
*
|
1994-10-18 |
1996-04-19 |
Sofab |
Dispositif pour l'inhalation de produits en poudre
|
DE19500764C2
(de)
*
|
1995-01-13 |
2001-09-27 |
Sofotec Gmbh & Co Kg |
Vorrichtung zum Verabreichen von Medikamenten in fester, in einem Luftstrom fein verteilter Form
|
DE19502725B4
(de)
*
|
1995-01-28 |
2004-03-04 |
Ing. Erich Pfeiffer Gmbh & Co Kg |
Austragvorrichtung für Medien
|
US5676643A
(en)
*
|
1995-02-13 |
1997-10-14 |
The Procter & Gamble Company |
Dispenser for friably releasing dry particulate medicaments
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5669973A
(en)
*
|
1995-06-06 |
1997-09-23 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing and retaining materials upon a substrate
|
US5714007A
(en)
*
|
1995-06-06 |
1998-02-03 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
|
US6672304B1
(en)
|
1995-06-08 |
2004-01-06 |
Innovative Devices, Llc |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
US20040237961A1
(en)
*
|
1995-06-08 |
2004-12-02 |
Snow John Medlin |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
DE19523516C1
(de)
*
|
1995-06-30 |
1996-10-31 |
Asta Medica Ag |
Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
|
US5642727A
(en)
*
|
1995-07-25 |
1997-07-01 |
David Sarnoff Research Center, Inc. |
Inhaler apparatus using a tribo-electric charging technique
|
US5823183A
(en)
*
|
1995-08-02 |
1998-10-20 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US6209538B1
(en)
*
|
1995-08-02 |
2001-04-03 |
Robert A. Casper |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5988163A
(en)
*
|
1995-08-02 |
1999-11-23 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
|
US5692496A
(en)
*
|
1995-08-02 |
1997-12-02 |
Innovative Devices, Llc |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
NL1001031C1
(nl)
*
|
1995-08-23 |
1997-02-25 |
Npk Ind Design B V |
Inrichting voor het afgeven van pillen uit een blisterverpakking.
|
CA2239292C
(en)
|
1995-12-07 |
2003-09-30 |
Jago Pharma Ag |
Inhalator designed to provide multiple doses of a dry pharmacological powder
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
US5823179A
(en)
|
1996-02-13 |
1998-10-20 |
1263152 Ontario Inc. |
Nebulizer apparatus and method
|
US5743251A
(en)
|
1996-05-15 |
1998-04-28 |
Philip Morris Incorporated |
Aerosol and a method and apparatus for generating an aerosol
|
US5871010A
(en)
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
AU5806898A
(en)
|
1996-12-31 |
1998-07-31 |
Inhale Therapeutic Systems |
Processes and compositions for spray drying hydrophobic drugs in organic solventsuspensions of hydrophilic excipients
|
DE19704849B4
(de)
*
|
1997-02-08 |
2011-02-17 |
Ing. Erich Pfeiffer Gmbh |
Austragvorrichtung für Medien
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5909822A
(en)
*
|
1997-05-03 |
1999-06-08 |
George; Donald C. |
Pill dispenser employing a sealed pill carrier
|
US5915560A
(en)
*
|
1997-05-03 |
1999-06-29 |
George; Donald C. |
Compartmentalized pill dispenser
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
ATE432727T1
(de)
|
1997-12-02 |
2009-06-15 |
Valois Sas |
Trockenpulverinhalator
|
CA2315777C
(en)
|
1998-01-16 |
2008-12-23 |
1263152 Ontario Inc. |
Indicating device for use with a dispensing device
|
KR100620338B1
(ko)
|
1998-03-16 |
2006-09-13 |
넥타르 테라퓨틱스 |
에어로졸형 활성 제제 전달 방법
|
US6082358A
(en)
|
1998-05-05 |
2000-07-04 |
1263152 Ontario Inc. |
Indicating device for aerosol container
|
US6729330B2
(en)
|
1998-05-05 |
2004-05-04 |
Trudell Medical International |
Indicating device for aerosol container
|
US6336453B1
(en)
|
1999-04-30 |
2002-01-08 |
Trudell Medical International |
Indicating device for aerosol container
|
US6257233B1
(en)
|
1998-06-04 |
2001-07-10 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
US6149774A
(en)
*
|
1998-06-10 |
2000-11-21 |
Delsys Pharmaceutical Corporation |
AC waveforms biasing for bead manipulating chucks
|
DE19831525A1
(de)
*
|
1998-07-14 |
2000-01-20 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
UA73924C2
(en)
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
US6234167B1
(en)
|
1998-10-14 |
2001-05-22 |
Chrysalis Technologies, Incorporated |
Aerosol generator and methods of making and using an aerosol generator
|
US6923979B2
(en)
|
1999-04-27 |
2005-08-02 |
Microdose Technologies, Inc. |
Method for depositing particles onto a substrate using an alternating electric field
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
MXPA01012533A
(es)
|
1999-06-05 |
2003-10-14 |
Innovata Biomed Ltd |
Sistema de suministro.
|
US6606992B1
(en)
|
1999-06-30 |
2003-08-19 |
Nektar Therapeutics |
Systems and methods for aerosolizing pharmaceutical formulations
|
US6730066B1
(en)
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
US6810872B1
(en)
|
1999-12-10 |
2004-11-02 |
Unisia Jecs Corporation |
Inhalant medicator
|
US6679256B2
(en)
|
1999-12-17 |
2004-01-20 |
Nektar Therapeutics |
Systems and methods for extracting powders from receptacles
|
US6427688B1
(en)
*
|
2000-02-01 |
2002-08-06 |
Dura Pharmaceuticals, Icn. |
Dry powder inhaler
|
US7069929B2
(en)
*
|
2000-02-01 |
2006-07-04 |
Quadrant Technologies Limited |
Dry powder inhaler
|
CA2401288A1
(en)
|
2000-02-28 |
2001-09-07 |
Vectura Limited |
Improvements in or relating to the delivery of oral drugs
|
US6883516B2
(en)
|
2000-04-27 |
2005-04-26 |
Chrysalis Technologies Incorporated |
Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
|
MY136453A
(en)
|
2000-04-27 |
2008-10-31 |
Philip Morris Usa Inc |
"improved method and apparatus for generating an aerosol"
|
US6948494B1
(en)
*
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
GB0015034D0
(en)
*
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
AR028746A1
(es)
*
|
2000-06-23 |
2003-05-21 |
Norton Health Care Ltd |
Cartucho de dosis previamente medidas para inhalador de polvo seco accionado por la respiracion, el inhalador y un metodo de provision de dosis previamente medidas de polvo seco
|
US7575761B2
(en)
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
AP1422A
(en)
|
2000-08-05 |
2005-06-05 |
Glaxo Group Ltd |
6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent.
|
US6948492B2
(en)
*
|
2000-08-15 |
2005-09-27 |
University Of Kentucky Research Foundation |
Programmable multi-dose intranasal drug delivery device
|
US6501052B2
(en)
|
2000-12-22 |
2002-12-31 |
Chrysalis Technologies Incorporated |
Aerosol generator having multiple heating zones and methods of use thereof
|
US7077130B2
(en)
|
2000-12-22 |
2006-07-18 |
Chrysalis Technologies Incorporated |
Disposable inhaler system
|
US6681998B2
(en)
|
2000-12-22 |
2004-01-27 |
Chrysalis Technologies Incorporated |
Aerosol generator having inductive heater and method of use thereof
|
US6799572B2
(en)
|
2000-12-22 |
2004-10-05 |
Chrysalis Technologies Incorporated |
Disposable aerosol generator system and methods for administering the aerosol
|
US6491233B2
(en)
|
2000-12-22 |
2002-12-10 |
Chrysalis Technologies Incorporated |
Vapor driven aerosol generator and method of use thereof
|
US6701921B2
(en)
|
2000-12-22 |
2004-03-09 |
Chrysalis Technologies Incorporated |
Aerosol generator having heater in multilayered composite and method of use thereof
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
CA2809180C
(en)
|
2001-03-20 |
2015-06-02 |
Trudell Medical International |
Nebulizer apparatus with an adjustable fluid orifice
|
US7045658B2
(en)
|
2001-03-22 |
2006-05-16 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
US7291608B2
(en)
|
2001-04-30 |
2007-11-06 |
Glaxo Group Limited |
Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
|
US6745760B2
(en)
|
2001-05-15 |
2004-06-08 |
Trudell Medical International |
Medicament applicator
|
US8061006B2
(en)
|
2001-07-26 |
2011-11-22 |
Powderject Research Limited |
Particle cassette, method and kit therefor
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
KR100912324B1
(ko)
|
2001-09-14 |
2009-08-14 |
글락소 그룹 리미티드 |
호흡기 질환 치료용 펜에탄올아민 유도체
|
AU2002333644A1
(en)
|
2001-09-17 |
2003-04-01 |
Glaxo Group Limited |
Dry powder medicament formulations
|
JP4261351B2
(ja)
|
2001-09-19 |
2009-04-30 |
アドヴェント ファーマセウティカルズ プロプライエタリー リミテッド |
吸入器
|
US6568390B2
(en)
|
2001-09-21 |
2003-05-27 |
Chrysalis Technologies Incorporated |
Dual capillary fluid vaporizing device
|
US6640050B2
(en)
|
2001-09-21 |
2003-10-28 |
Chrysalis Technologies Incorporated |
Fluid vaporizing device having controlled temperature profile heater/capillary tube
|
US7931022B2
(en)
*
|
2001-10-19 |
2011-04-26 |
Respirks, Inc. |
Method and apparatus for dispensing inhalator medicament
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
US6804458B2
(en)
*
|
2001-12-06 |
2004-10-12 |
Chrysalis Technologies Incorporated |
Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate
|
US6681769B2
(en)
|
2001-12-06 |
2004-01-27 |
Crysalis Technologies Incorporated |
Aerosol generator having a multiple path heater arrangement and method of use thereof
|
US6701922B2
(en)
|
2001-12-20 |
2004-03-09 |
Chrysalis Technologies Incorporated |
Mouthpiece entrainment airflow control for aerosol generators
|
US7458373B2
(en)
*
|
2002-01-15 |
2008-12-02 |
Philip Morris Usa Inc. |
Aerosol generator for drug formulation
|
GB0217199D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0201677D0
(en)
*
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
US20060187750A1
(en)
*
|
2002-03-01 |
2006-08-24 |
Victor Aldrich |
Rotary blending apparatus and system
|
WO2003078448A1
(en)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation of protein methylation and phosphoprotein phosphate
|
US7004164B2
(en)
|
2002-03-21 |
2006-02-28 |
Trudell Medical International |
Indicating device for aerosol container
|
US7448184B2
(en)
*
|
2002-03-26 |
2008-11-11 |
Glaxo Group Limited |
Method for forming a laminate assembly with an ultrasonic welder
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
US20030235538A1
(en)
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
DE10217929A1
(de)
*
|
2002-04-22 |
2003-11-06 |
Sixp Ag |
Vorrichtung zur Ausgabe von Tabletten
|
DE60318193T2
(de)
|
2002-04-25 |
2008-12-04 |
Glaxo Group Ltd., Greenford |
Phenethanolaminderivate
|
EP1497629A1
(en)
*
|
2002-04-25 |
2005-01-19 |
Glaxo Group Limited |
Magnetoacoustic sensor system and associated method for sensing environmental conditions
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
GB2388040B
(en)
*
|
2002-05-02 |
2005-12-14 |
Robert Jeremy West |
Nicotine inhalation device
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
AU2003222642A1
(en)
*
|
2002-05-10 |
2003-11-11 |
Chrysalis Technologies Incorporated |
Aerosol generator for drug formulation and methods of generating aerosol
|
WO2003107397A2
(en)
*
|
2002-05-15 |
2003-12-24 |
Glaxo Group Limited |
Microelectromechanical system and method for determining temperature and moisture profiles within pharmaceutical packaging
|
US6904908B2
(en)
|
2002-05-21 |
2005-06-14 |
Trudell Medical International |
Visual indicator for an aerosol medication delivery apparatus and system
|
US7185651B2
(en)
|
2002-06-18 |
2007-03-06 |
Nektar Therapeutics |
Flow regulator for aerosol drug delivery and methods
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
US20050251289A1
(en)
*
|
2002-07-25 |
2005-11-10 |
Bonney Stanley G |
Medicament dispenser
|
US20050268908A1
(en)
*
|
2002-07-25 |
2005-12-08 |
Bonney Stanley G |
Medicament dispenser
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AU2003270321B2
(en)
|
2002-09-06 |
2008-04-03 |
Philip Morris Products S.A. |
Aerosol generating devices and methods for generating aerosols having controlled particle sizes
|
WO2004024308A1
(en)
*
|
2002-09-13 |
2004-03-25 |
Glaxo Group Limited |
Coated blending system
|
US6772757B2
(en)
|
2002-10-25 |
2004-08-10 |
Chrysalis Technologies Incorporated |
Concentric controlled temperature profile fluid vaporizing device
|
ES2302956T3
(es)
|
2002-10-28 |
2008-08-01 |
Glaxo Group Limited |
Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias.
|
WO2004060260A2
(en)
*
|
2002-12-18 |
2004-07-22 |
Glaxo Group Limited |
Drug delivery system with vented mouthpiece
|
US20040173211A1
(en)
*
|
2003-01-14 |
2004-09-09 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
JP2006516517A
(ja)
*
|
2003-02-05 |
2006-07-06 |
テッダム,マーティン,ジョン |
ディスペンサー
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
EP1488819A1
(en)
*
|
2003-06-16 |
2004-12-22 |
Rijksuniversiteit te Groningen |
Dry powder inhaler and method for pulmonary inhalation of dry powder
|
GB0315509D0
(en)
*
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
AR045914A1
(es)
|
2003-07-17 |
2005-11-16 |
Glaxo Group Ltd |
Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima
|
US7367334B2
(en)
|
2003-08-27 |
2008-05-06 |
Philip Morris Usa Inc. |
Fluid vaporizing device having controlled temperature profile heater/capillary tube
|
PL1677795T3
(pl)
|
2003-10-14 |
2011-05-31 |
Glaxo Group Ltd |
Antagoniści receptora muskarynowego acetylocholiny
|
UY28567A1
(es)
|
2003-10-17 |
2005-05-31 |
Glaxo Group Ltd |
Antagonistas de receptores de acetilcolina muscarinicos
|
WO2005044173A1
(en)
*
|
2003-10-27 |
2005-05-19 |
Oriel Therapeutics, Inc. |
Blister packages and associated methods of fabricating dry powder drug containment systems
|
US7621273B2
(en)
|
2003-10-28 |
2009-11-24 |
Trudell Medical International |
Indicating device with warning dosage indicator
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
CA2547782A1
(en)
*
|
2003-12-03 |
2005-06-16 |
Microdrug Ag |
Medical product containing tiotropium
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
US7100530B2
(en)
|
2003-12-15 |
2006-09-05 |
Trudell Medical International, Inc. |
Dose indicating device
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US8147426B2
(en)
*
|
2003-12-31 |
2012-04-03 |
Nipro Diagnostics, Inc. |
Integrated diagnostic test system
|
WO2005095407A1
(en)
|
2004-03-17 |
2005-10-13 |
Glaxo Group Limited |
M3 muscarinic acetylcholine receptor antagonists
|
US7846973B2
(en)
|
2004-04-02 |
2010-12-07 |
Theravance, Inc. |
Chemical process and new crystalline form
|
CA2562386C
(en)
|
2004-04-21 |
2014-11-18 |
Innovata Biomed Limited |
Inhaler
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
MY144753A
(en)
|
2004-04-27 |
2011-10-31 |
Glaxo Group Ltd |
Muscarinic acetylcholine receptor antagonists
|
JP2007537261A
(ja)
|
2004-05-13 |
2007-12-20 |
グラクソ グループ リミテッド |
ムスカリン性アセチルコリン受容体アンタゴニスト
|
GB0418738D0
(en)
*
|
2004-08-23 |
2004-09-22 |
3M Innovative Properties Co |
Medicinal aerosol formulation receptacle and production thereof
|
US7543582B2
(en)
|
2004-09-20 |
2009-06-09 |
Trudell Medical International |
Dose indicating device with display elements attached to container
|
NZ554930A
(en)
*
|
2004-10-21 |
2010-04-30 |
Boehringer Ingelheim Int |
Blister for inhalers
|
WO2006047663A2
(en)
*
|
2004-10-26 |
2006-05-04 |
The University Of North Carolina At Chapel Hill |
Aerosol generation of therapeutic agents
|
JP2006130143A
(ja)
*
|
2004-11-08 |
2006-05-25 |
Hitachi Ltd |
吸入式投薬器及び薬剤カートリッジ
|
JP2008519984A
(ja)
*
|
2004-11-12 |
2008-06-12 |
グラクソ グループ リミテッド |
音響変換器を備えるセンサシステム
|
JP5189369B2
(ja)
|
2005-01-20 |
2013-04-24 |
トルーデル メディカル インターナショナル |
分与装置
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
EP1843734A4
(en)
|
2005-02-03 |
2008-09-10 |
Signum Biosciences Inc |
COMPOSITIONS AND METHOD FOR INTENSIFYING COGNITIVE FUNCTIONS
|
RU2007133547A
(ru)
|
2005-02-10 |
2009-03-20 |
Глаксо Груп Лимитед (GB) |
Способы получения лактозы с использованием методов предварительной сортировки и приготовляемые из нее фармацевтические композиции
|
AR053450A1
(es)
|
2005-03-25 |
2007-05-09 |
Glaxo Group Ltd |
Derivados de 3,4-dihidro-pirimido(4,5-d)pirimidin-2-(1h)-ona 1,5,7 trisustituidos como inhibidores de la quinasa p38
|
PE20061351A1
(es)
|
2005-03-25 |
2007-01-14 |
Glaxo Group Ltd |
COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
|
GB0507711D0
(en)
|
2005-04-15 |
2005-05-25 |
Vectura Group Plc |
Improved blister piercing
|
US8653028B2
(en)
|
2005-04-29 |
2014-02-18 |
Rui Rong Yuan |
Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
US9345745B2
(en)
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
JP2008539839A
(ja)
*
|
2005-05-04 |
2008-11-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
複数回投与量の医薬組成物を含有する吸入装置
|
DE102005035705A1
(de)
|
2005-07-27 |
2007-02-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Arzneimittelblister
|
WO2007022351A2
(en)
|
2005-08-18 |
2007-02-22 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists
|
CA2620123C
(en)
*
|
2005-08-24 |
2011-11-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treating and monitoring inflammation and redox imbalance in cystic fibrosis
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
US20130131007A1
(en)
|
2005-09-07 |
2013-05-23 |
Bebaas, Inc. |
Vitamin b12 compositions
|
US20070178141A1
(en)
*
|
2005-09-07 |
2007-08-02 |
Bebaas, Inc. |
Vitamin B12 compositions
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
EP1795221A1
(en)
*
|
2005-12-02 |
2007-06-13 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
US8037880B2
(en)
*
|
2006-04-07 |
2011-10-18 |
The University Of Western Ontario |
Dry powder inhaler
|
EP1844808A1
(de)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Medikamenten-Ausgabevorrichtung
|
EP1844809A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator
|
DE102006023662A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
US9457161B2
(en)
|
2006-05-18 |
2016-10-04 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
DE102006043637A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Zerstäuber
|
US8141550B2
(en)
|
2006-08-01 |
2012-03-27 |
Trudell Medical International |
Dispensing device
|
WO2008024375A2
(en)
|
2006-08-21 |
2008-02-28 |
Trudell Medical International |
Respiratory muscle endurance training device and method for the use thereof
|
DE102006045788A1
(de)
|
2006-09-26 |
2008-03-27 |
Alfred Von Schuckmann |
Spender für pulverförmige Massen
|
AU2007309412B2
(en)
|
2006-10-25 |
2011-10-20 |
Novartis Ag |
Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
|
GB0621957D0
(en)
*
|
2006-11-03 |
2006-12-13 |
Vectura Group Plc |
Inhaler devices and bespoke pharmaceutical compositions
|
EP1925295A1
(de)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stabile Pulverformulierung enthaltend ein Anticholinergikum
|
WO2008086413A2
(en)
|
2007-01-09 |
2008-07-17 |
Mystic Pharmaceuticals, Inc. |
Intranasal cartridge devices
|
ES2624196T3
(es)
|
2007-01-10 |
2017-07-13 |
Purdue Research Foundation |
Inhibidores polipéptidicos de HSP27 quinasa y usos de los mismos
|
AR065804A1
(es)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
|
EP1992380A1
(en)
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992378A1
(en)
*
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992373A1
(en)
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
US9248076B2
(en)
|
2007-05-16 |
2016-02-02 |
Mystic Pharmaceuticals, Inc. |
Dose dispensing containers
|
EP1992374A1
(en)
*
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992376A1
(en)
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992372A1
(en)
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992379A1
(en)
*
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP1992377A1
(en)
*
|
2007-05-16 |
2008-11-19 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP2150301B1
(en)
*
|
2007-06-01 |
2016-08-24 |
Boehringer Ingelheim International GmbH |
Dispensing device
|
AT505246B8
(de)
*
|
2007-06-01 |
2009-06-15 |
Croma Pharma Gmbh |
Container für eine mehrzahl von einzeldosen sowie applikator für derartige container
|
JP5703466B2
(ja)
*
|
2007-08-07 |
2015-04-22 |
パーデュー・リサーチ・ファウンデーションPurdue Research Foundation |
キナーゼ阻害薬およびその使用
|
EP2042208A1
(en)
*
|
2007-09-25 |
2009-04-01 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
EP2082763A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
JP2011512209A
(ja)
*
|
2008-02-20 |
2011-04-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
粉末吸入器
|
CA2716511C
(en)
*
|
2008-02-21 |
2015-06-02 |
Trudell Medical International |
Respiratory muscle endurance training device and method for the use thereof
|
US20090235929A1
(en)
*
|
2008-03-19 |
2009-09-24 |
Marc Egen |
Powder inhalers
|
US8082873B2
(en)
|
2008-05-05 |
2011-12-27 |
Trudell Medical International |
Drive mechanism for an indicating device
|
CA2725143A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Neurotez, Inc. |
Methods for treating progressive cognitive disorders related to neurofibrillary tangles
|
US8181591B1
(en)
|
2008-05-23 |
2012-05-22 |
Trudell Medical International |
Domed actuator for indicating device
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
MX2011003232A
(es)
*
|
2008-09-26 |
2011-04-21 |
Oriel Therapeutics Inc |
Mecanismos inhaladaores con perforadores radialmente desviados y métodos relacionados.
|
WO2010036839A2
(en)
|
2008-09-26 |
2010-04-01 |
Oriel Therapeutics, Inc. |
Inhalers with airway disks having discrete airway channels and related disks and methods
|
JP5470393B2
(ja)
|
2008-09-26 |
2014-04-16 |
オリエル・セラピューティクス,インコーポレイテッド |
ドライパウダー吸入器
|
WO2010039201A2
(en)
*
|
2008-09-30 |
2010-04-08 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
|
MX2011003245A
(es)
*
|
2008-10-01 |
2011-04-26 |
Oriel Therapeutics Inc |
Inhaladores de polvo seco con mecanismos de perforacion giratorios y dispositivos y metodos relacionados.
|
MX2011003799A
(es)
*
|
2008-10-08 |
2011-06-16 |
Astrazeneca Ab |
Inhalador con medio indicador audible.
|
CA2741302C
(en)
*
|
2008-10-20 |
2017-02-28 |
Moerae Matrix, Inc. |
Mapkap kinase inhibitor polypeptide for treating or preventing adhesions
|
EP2179760B1
(en)
|
2008-10-22 |
2013-02-27 |
Trudell Medical International |
Modular Aerosol Delivery System
|
CN102300581B
(zh)
*
|
2008-11-04 |
2016-12-21 |
尼古拉斯·泰萨普塞蒂斯 |
用于治疗因神经原纤维缠结和β淀粉状蛋白的积聚引起的进行性认知功能障碍的瘦蛋白组合物和方法
|
CA2744913A1
(en)
*
|
2008-12-03 |
2010-06-10 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
ES2685505T3
(es)
*
|
2008-12-10 |
2018-10-09 |
Purdue Research Foundation |
Inhibidor de cinasas basado en péptidos de permeación celular
|
GB0901520D0
(en)
|
2009-01-30 |
2009-03-11 |
Vectura Delivery Devices Ltd |
Inhaler
|
DK3578169T3
(da)
|
2009-02-26 |
2024-07-22 |
Glaxo Group Ltd |
Farmaceutiske formuleringer omfattende 4-{(1R)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
JP2012520701A
(ja)
|
2009-03-17 |
2012-09-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
小出し器具、貯蔵器具及び調合薬を小出しする方法
|
WO2010135672A1
(en)
*
|
2009-05-21 |
2010-11-25 |
Microdose Therapeutx, Inc. |
Rotary cassette system for dry powder inhaler
|
US8985101B2
(en)
|
2009-05-21 |
2015-03-24 |
Microdose Therapeutx, Inc. |
Method and device for clamping a blister within a dry powder inhaler
|
US20120171126A1
(en)
|
2009-06-16 |
2012-07-05 |
Purakkattle Biju J |
NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF
|
CN102762573B
(zh)
|
2009-07-24 |
2015-09-16 |
阿马曾提斯公司 |
用于在神经退行性障碍中保护脑部健康的化合物、组合物和方法
|
WO2011017132A2
(en)
*
|
2009-07-27 |
2011-02-10 |
Purdue Research, Foundation |
Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
CN104338219B
(zh)
|
2010-01-05 |
2017-10-24 |
微剂量治疗技术公司 |
吸入设备和方法
|
US8135497B2
(en)
|
2010-01-13 |
2012-03-13 |
Joslyn Matthew I |
Portable, personal medication dispensing apparatus and method
|
DK2547308T3
(en)
|
2010-03-18 |
2014-11-17 |
Medcomb Holding Aps |
INSULABLE DISPOSAL CONTAINER FOR PHARMACEUTICAL COMPOSITIONS
|
USD641076S1
(en)
|
2010-03-26 |
2011-07-05 |
Oriel Therapeutics, Inc. |
Dry powder inhaler
|
USD635246S1
(en)
|
2010-03-26 |
2011-03-29 |
Oriel Therapeutics, Inc. |
Dose disk for dry powder inhalers
|
AU2011298409B2
(en)
|
2010-08-31 |
2013-11-21 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
AU2011298315B2
(en)
|
2010-08-31 |
2014-08-28 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
USD666098S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
USD666096S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
USD666493S1
(en)
|
2010-11-01 |
2012-09-04 |
Colgate-Palmolive Company |
Cap for a container
|
USD666099S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
USD666492S1
(en)
|
2010-11-01 |
2012-09-04 |
Colgate-Palmolive Company |
Cap for a container
|
USD666097S1
(en)
|
2010-11-01 |
2012-08-28 |
Colgate-Palmolive Company |
Cap for a container
|
US9297813B2
(en)
|
2010-11-11 |
2016-03-29 |
Agency For Science, Technology And Research |
Targeting metabolic enzymes in human cancer
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
WO2012142320A2
(en)
|
2011-04-12 |
2012-10-18 |
Moerae Matrix Inc |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
CN103717231B
(zh)
|
2011-05-19 |
2016-08-17 |
萨瓦拉股份有限公司 |
干粉万古霉素组合物以及相关方法
|
US8585659B2
(en)
*
|
2011-05-31 |
2013-11-19 |
Mystic Pharmaceuticals, Inc. |
Piercing device for drug delivery systems
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
EP2589381B1
(en)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions for improving or preserving lung function in a patient with a pulmonary disorder
|
WO2013134636A1
(en)
|
2012-03-09 |
2013-09-12 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
MX2014012989A
(es)
|
2012-04-27 |
2015-01-22 |
Glaxo Group Ltd |
Compuestos novedosos.
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
JP2015530387A
(ja)
|
2012-09-04 |
2015-10-15 |
エライゾン ファーマシューティカルズ, エルエルシー |
脂質複合体化シスプラチンによる肺癌の再発防止
|
CA2891348C
(en)
|
2012-11-28 |
2020-04-28 |
Intercept Pharmaceuticals, Inc. |
Treatment of pulmonary disease
|
GB201301192D0
(en)
|
2013-01-23 |
2013-03-06 |
Vectura Delivery Devices Ltd |
A blister piercing element for a dry powder inhaler
|
JP2015037466A
(ja)
*
|
2013-04-08 |
2015-02-26 |
ニップファーマ株式会社 |
薬剤吸入デバイス
|
CN105873913B
(zh)
|
2013-09-10 |
2019-12-03 |
得克萨斯系统大学评议会 |
靶向截短的腺瘤性结肠息肉(apc)蛋白的治疗法
|
CA2936301C
(en)
|
2013-10-15 |
2021-06-08 |
Mystic Pharmaceuticals, Inc. |
Controllable rate turbulating nozzle
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
AU2015250132B2
(en)
*
|
2014-04-24 |
2020-11-26 |
Questa Corporation |
Multi-size pill splitter and methods
|
SG11201609276RA
(en)
|
2014-05-12 |
2016-12-29 |
Glaxosmithkline Ip No 2 Ltd |
Pharmaceutical compositions comprising danirixin for treating infectious diseases
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
DK3212212T3
(da)
|
2014-10-31 |
2020-12-21 |
Univ Monash |
Pulverformulering
|
JP2018501201A
(ja)
|
2014-11-17 |
2018-01-18 |
モイライ マトリックス インコーポレイテッド |
異常な線維芽細胞増殖および細胞外マトリックス沈着を特徴とする疾患、状態、またはプロセスを予防または処置するための組成物および方法
|
KR102674191B1
(ko)
|
2014-12-10 |
2024-06-11 |
하이퍼스템 에스에이 |
뇌암 줄기 세포의 성장, 이동 및 침습성 감소 그리고 뇌종양을 가진 환자의 생존 개선 방법 및 조성물
|
USD754919S1
(en)
*
|
2014-12-19 |
2016-04-26 |
Fontem Holdings 4 B.V. |
Mouthpiece
|
CA2972916A1
(en)
|
2015-01-08 |
2016-07-14 |
Moerae Matrix, Inc. |
Formulation of mk2 inhibitor peptides
|
CA2974661A1
(en)
|
2015-01-21 |
2016-07-28 |
Mylan Inc. |
Medication packaging and dose regimen system
|
US20160264658A1
(en)
|
2015-03-11 |
2016-09-15 |
Glaxosmithkline Intellectual Property Development Limited |
TSLP Binding Proteins
|
AU2016229017A1
(en)
|
2015-03-12 |
2017-09-28 |
Moerae Matrix, Inc. |
Use of MK2 inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
|
EP3297711A4
(en)
*
|
2015-05-22 |
2019-01-16 |
Compressed Perforated Puck Technologies Inc. |
SPRAY APPARATUS FOR COMPRESSED TABLET AND BULK PLANT SOURCE MATERIALS
|
CA2987071A1
(en)
|
2015-06-10 |
2016-12-15 |
Hackensack University Medical Center |
Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
|
ES2834490T3
(es)
|
2015-06-15 |
2021-06-17 |
Glaxosmithkline Ip Dev Ltd |
Reguladores de NRF2
|
KR20180017038A
(ko)
|
2015-06-15 |
2018-02-20 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Nrf2 조절제
|
ES2980945T3
(es)
|
2015-06-15 |
2024-10-03 |
Glaxosmithkline Intellectual Property Dev |
Reguladores de NRF2
|
US10112948B2
(en)
|
2015-07-06 |
2018-10-30 |
The Board Of Regents Of The University Of Texas System |
Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
|
DK3322417T3
(da)
|
2015-07-15 |
2023-10-30 |
Univ Texas |
Målretning af emopamil-bindingsprotein (EBP) med små molekyler, der inducerer et unormalt feedbackrespons ved sænkning af endogen cholesterolsyntese
|
TW201722965A
(zh)
|
2015-08-16 |
2017-07-01 |
葛蘭素史密斯克藍智慧財產發展有限公司 |
用於抗菌應用之化合物
|
JP2018529745A
(ja)
|
2015-10-06 |
2018-10-11 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしてのビアリールピラゾール
|
EP3371167A1
(en)
|
2015-10-06 |
2018-09-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as nrf2 regulators
|
CN108348470A
(zh)
|
2015-11-18 |
2018-07-31 |
葛兰素史克知识产权第二有限公司 |
利巴韦林的药物组合物
|
EP3405175A4
(en)
|
2016-01-20 |
2019-09-25 |
Flurry Powders, LLC |
Encapsulation of Lipophilic Ingredients in Dispersible Aerosol Powder Incorporated Powder
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
WO2017199215A1
(en)
|
2016-05-19 |
2017-11-23 |
Trudell Medical International |
Smart valved holding chamber
|
US10786638B2
(en)
|
2016-07-08 |
2020-09-29 |
Trudell Medical International |
Nebulizer apparatus and method
|
EP3984579B1
(en)
|
2016-07-08 |
2024-09-04 |
Trudell Medical International Inc. |
Smart oscillating positive expiratory pressure device
|
KR20190049865A
(ko)
|
2016-09-20 |
2019-05-09 |
글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 |
Trpv4 길항제
|
EP3515889A1
(en)
|
2016-09-20 |
2019-07-31 |
GlaxoSmithKline Intellectual Property (No. 2) Limited |
Trpv4 antagonists
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
KR20190088404A
(ko)
|
2016-12-06 |
2019-07-26 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
3-(2,3-디히드로-1h-인덴-5-일)프로판산 유도체 및 nrf2 조절제로서의 그의 용도
|
JP7093353B2
(ja)
|
2016-12-09 |
2022-06-29 |
トゥルーデル メディカル インターナショナル |
スマートネブライザ
|
US20200031820A1
(en)
|
2016-12-12 |
2020-01-30 |
Glsxosmithkline Intellectual Property Development Limited |
3-carboxylic acid pyrroles as nrf2 regulators
|
JP2020500918A
(ja)
|
2016-12-12 |
2020-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしてのn−アリールピラゾール
|
US11117905B2
(en)
|
2016-12-14 |
2021-09-14 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl heterocycles as NRF2 activators
|
JP2020502136A
(ja)
|
2016-12-14 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしてのビスアリールアミド
|
ES2848699T3
(es)
|
2016-12-14 |
2021-08-11 |
Glaxosmithkline Ip Dev Ltd |
Compuestos de 3-oxo-1,4-diazepinilo como activadores de NRF2
|
WO2018109649A1
(en)
|
2016-12-15 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Ether linked triazoles as nrf2 regulators
|
CA3044773A1
(en)
|
2016-12-15 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activators
|
CN108328122B
(zh)
*
|
2017-01-17 |
2024-04-12 |
李和伟 |
一种制剂盒
|
ES2901875T3
(es)
|
2017-04-24 |
2022-03-24 |
Cocrystal Pharma Inc |
Derivados de la pirrolopirimidina útiles como inhibidores de la replicación del virus de la influenza
|
WO2019116230A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
WO2019135191A1
(en)
|
2018-01-04 |
2019-07-11 |
Trudell Medical International |
Smart oscillating positive expiratory pressure device
|
MX2020007521A
(es)
|
2018-01-17 |
2022-12-05 |
Glaxosmithkline Ip Dev Ltd |
Inhibidores de pi4kiii.
|
CN108815653B
(zh)
*
|
2018-04-19 |
2020-11-10 |
山西白求恩医院 |
一种气体速度可调节的雾化器
|
JP2021524469A
(ja)
|
2018-05-23 |
2021-09-13 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2アクチベーターとしてのインダン
|
MX2021000917A
(es)
|
2018-07-27 |
2021-06-23 |
Cocrystal Pharma Inc |
Derivados de pirrolo[2,3-b]piridina como inhibidores de la replicación del virus de la gripe.
|
GB201812671D0
(en)
|
2018-08-03 |
2018-09-19 |
Coalesce Product Dev Ltd |
An inhaler device
|
JP7472108B2
(ja)
|
2018-09-10 |
2024-04-22 |
コクリスタル ファーマ,インコーポレイテッド |
ピリドピラジン系及びピリドトリアジン系インフルエンザウィルス複製阻害剤
|
ES2939148T3
(es)
|
2018-10-17 |
2023-04-19 |
Cocrystal Pharma Inc |
Combinaciones de inhibidores de la replicación del virus de la influenza
|
MX2021005582A
(es)
|
2018-11-13 |
2021-06-30 |
Cocrystal Pharma Inc |
Formulaciones de terapias contra la gripe.
|
WO2020112716A1
(en)
|
2018-11-26 |
2020-06-04 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
DE102019134285A1
(de)
|
2019-01-15 |
2020-07-16 |
Nuuvera Deutschland GmbH |
Vorrichtung und Verfahren zum Extrahieren und Aspirieren von Wirkstoffen, insbesondere aus der Cannabispflanze
|
CN109939309B
(zh)
*
|
2019-04-01 |
2021-06-01 |
中国科学院大学深圳医院(光明) |
粉状物吸入装置
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
US11712175B2
(en)
|
2019-08-27 |
2023-08-01 |
Trudell Medical International |
Smart oscillating positive expiratory pressure device with feedback indicia
|
WO2021188620A1
(en)
|
2020-03-17 |
2021-09-23 |
Cocrystal Pharma Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
MX2022012714A
(es)
|
2020-04-10 |
2022-12-15 |
Cocrystal Pharma Inc |
Inhibidores de la replicacion de norovirus y coronavirus.
|
WO2021216547A1
(en)
|
2020-04-20 |
2021-10-28 |
Sorrento Therapeutics, Inc. |
Pulmonary administration of ace2 polypeptides
|
CN112298819A
(zh)
*
|
2020-10-28 |
2021-02-02 |
朱爱庆 |
一种具有防潮功能的定量取药瓶
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
EP4323039A1
(en)
|
2021-04-14 |
2024-02-21 |
The University of North Carolina at Chapel Hill |
Hot porous-solid metering systems and methods for generation of therapeutic aerosols by evaporation/condensation
|
CN118103351A
(zh)
|
2021-08-03 |
2024-05-28 |
共晶制药公司 |
冠状病毒抑制剂
|
US11517704B1
(en)
*
|
2021-12-06 |
2022-12-06 |
Stat Capsule Inc. |
Wristband capsule crusher
|
CN114098624B
(zh)
*
|
2021-12-30 |
2022-09-02 |
山东第一医科大学附属省立医院(山东省立医院) |
一种可视的直肠快速内检装置
|